EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access

Feasibility and Preliminary Efficacy of a “Sit Less” Program Leveraging Fitbit Tracking and Tailored Text Messages in Cardiometabolic Disease: Findings From 2 Parallel Randomized Controlled Trials in Coronary Artery Disease and Type 2 Diabetes

Chorong Park iD, Mary S Dietrich iD, Britta Larsen iD, Lindsay S Mayberry iD, Abigail Doyle iD, Soojung Ahn iD, Jason Jean, Kevin Maquiling, Mulubrhan F Mogos iD, James M Muchira iD, Shelagh Mulvaney iD

JMIR mHealth and uHealth · 25.08.2026 · 14 · e56497

DOI: 10.2196/56497 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift JMIR mHealth and uHealth, online erschienen am 25.08.2026. Verfasst von Chorong Park und 10 weiteren Autor:innen. Beteiligte Einrichtung: College of Nursing, Seoul National University, 103 Daehak-ro, Jongno-gu, Main Nursing Building #501, Seoul, 03080, Republic of Korea, 82 27408827. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Text Messaging, Coronary Artery Disease, Fitness Trackers. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Individuals with cardiometabolic disease typically average 10 to 14 hours of daily sedentary time, which increases the risk of cardiovascular disease.

Objective

This study aimed to evaluate the feasibility, acceptability, and preliminary efficacy of a “Sit Less” program in reducing sedentary behavior in people with cardiometabolic disease.

Methods

Participants with cardiovascular disease or type 2 diabetes underwent separate randomization into the Sit Less intervention or the control group. Sit Less included 1 in-person counseling session, a Fitbit, a smart water bottle, and tailored weekly text messages for 12 weeks. Control group participants received the American Heart Association’s “Answers by Heart” booklet. Sedentary behavior was measured using the activPAL for 7 days at baseline and postintervention. The secondary outcomes included physical activity, cardiometabolic biomarkers, continuous glucose monitoring metrics, and psychological factors. Generalized linear models estimated adjusted between-group differences, controlling for baseline values, cohort, cohort×group interaction, and leisure-time exercise.

Results

Of the 37 randomized participants, 35 (95%) completed the study (Sit Less: n=17, 48.6%; and control: n=18, 51.4%). Of the 35 participants who completed the study, 62% (n=21) were men, the median age was 67 (54-72) years, and their baseline sedentary time was approximately 10.4 hours per day. Sit Less participants demonstrated high adherence, including a text response rate of 81% and a median Fitbit wear time of 15 hours per day on 6.8 days per week, and 15 (88%) of 17 participants reported satisfaction with the program. Compared with the control group, Sit Less participants showed greater reductions in total sedentary time (adjusted mean difference −17.3 min/d, 95% CI −63 to 28; P=.45) and prolonged sedentary time of >30 minutes (−39.5 min/d, 95% CI −100 to 21; P=.20) and >60 minutes (−49.9 min/d, 95% CI −102 to 2; P=.06) and increases in sit-to-stand transitions (4.2 per day, 95% CI −2 to 10; P=.13), although none were statistically significant. Hemoglobin A1c was lower in the Sit Less group than in the control group (adjusted mean difference −0.4%, 95% CI −0.8 to −0.1; P=.04). Continuous glucose monitoring outcomes, including mean glucose (−6.0 mg/dL, 95% CI −14.9 to 2.8; P=.18) and time in range (2.1%, 95% CI −4.8 to 9.1; P=.54), were not statistically significant but demonstrated similar directional changes. Other cardiometabolic biomarkers, physical activity, and psychological outcomes were not significantly different, except for lower self-efficacy for moderate physical activity in the Sit Less group (−0.6, 95% CI −1.1 to −0.2; P=.003).

Conclusions

The Sit Less intervention was feasible and acceptable and showed possible improvements in sedentary behavior and glycemic outcomes. Although this pilot study had a small sample size and limited statistical power, with multiple outcomes examined and wide CIs observed, these findings support evaluation in larger, adequately powered trials. Trial Registration ClinicalTrials.gov NCT05534256; https://clinicaltrials.gov/study/NCT05534256 and ClinicalTrials.gov NCT05691452; https://clinicaltrials.gov/study/NCT05691452 International Registered Report Identifier (IRRID) RR2-10.1371/journal.pone.0302582

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Text MessagingCoronary Artery DiseaseFitness TrackersHumansMaleFemaleMiddle AgedFeasibility StudiesSedentary BehaviorAgedDigital HealthExercise

Stichwörter der Autor:innen

activity trackercardiovascular diseasediabetesdigital healthmHealthmobile healthsedentary behaviortext messages

Autor:innen und Institutionen

  • College of Nursing, Seoul National University, 103 Daehak-ro, Jongno-gu, Main Nursing Building #501, Seoul, 03080, Republic of Korea, 82 27408827.
  • The Research Institute of Nursing Science, Seoul National University, Seoul, Seoul, Republic of Korea.
  • School of Transdisciplinary Innovations, Seoul National University, Seoul, Republic of Korea.
  • School of Nursing, Vanderbilt University, Nashville, TN, United States.
  • Department of Biostatistics, School of Medicine, Vanderbilt University, Nashville, TN, United States.
  • Herbert Wertheim School of Public Health and Human Longevity Science, University of California San Diego, La Jolla, CA, United States.

ORCID-Profile: Chorong Park, Mary S Dietrich, Britta Larsen, Lindsay S Mayberry, Abigail Doyle, Soojung Ahn, Mulubrhan F Mogos, James M Muchira, Shelagh Mulvaney

Förderung

  • NIDDK NIH HHS

Zitieren

APA

Park, C., Dietrich, M. S., Larsen, B., Mayberry, L. S., Doyle, A., Ahn, S., Jean, J., Maquiling, K., Mogos, M. F., Muchira, J. M., & Mulvaney, S. (2026). Feasibility and Preliminary Efficacy of a “Sit Less” Program Leveraging Fitbit Tracking and Tailored Text Messages in Cardiometabolic Disease: Findings From 2 Parallel Randomized Controlled Trials in Coronary Artery Disease and Type 2 Diabetes. JMIR mHealth and uHealth, 14, e56497. https://doi.org/10.2196/56497

Vancouver

Park C, Dietrich MS, Larsen B, Mayberry LS, Doyle A, Ahn S, et al. Feasibility and Preliminary Efficacy of a “Sit Less” Program Leveraging Fitbit Tracking and Tailored Text Messages in Cardiometabolic Disease: Findings From 2 Parallel Randomized Controlled Trials in Coronary Artery Disease and Type 2 Diabetes. JMIR mHealth and uHealth. 2026;14:e56497. doi:10.2196/56497

BibTeX
@article{Park2026,
  author = {Park, Chorong and Dietrich, Mary S and Larsen, Britta and Mayberry, Lindsay S and Doyle, Abigail and Ahn, Soojung and Jean, Jason and Maquiling, Kevin and Mogos, Mulubrhan F and Muchira, James M and Mulvaney, Shelagh},
  title = {Feasibility and Preliminary Efficacy of a “Sit Less” Program Leveraging Fitbit Tracking and Tailored Text Messages in Cardiometabolic Disease: Findings From 2 Parallel Randomized Controlled Trials in Coronary Artery Disease and Type 2 Diabetes},
  journal = {JMIR mHealth and uHealth},
  year = {2026},
  volume = {14},
  pages = {e56497},
  doi = {10.2196/56497}
}
Kostenlos starten →